title: Report of the Task Force on the Availability of Cardiovascular Drugs to the Medically Indigent.
authors.forename: H P
authors.initials: HP
authors.lastname: Dustan
authors.forename: L R
authors.initials: LR
authors.lastname: Caplan
authors.forename: C L
authors.initials: CL
authors.lastname: Curry
authors.forename: A C
authors.initials: AC
authors.lastname: De Leon
authors.forename: F L
authors.initials: FL
authors.lastname: Douglas
authors.forename: W
authors.initials: W
authors.lastname: Frishman
authors.forename: M N
authors.initials: MN
authors.lastname: Hill
authors.forename: R L
authors.initials: RL
authors.lastname: Washington
authors.forename: S
authors.initials: S
authors.lastname: Steigerwalt
authors.forename: N B
authors.initials: NB
authors.lastname: Shulman
mesh_terms: D002309:Cardiology; D002317:Cardiovascular Agents; D002318:Cardiovascular Diseases / Q000191:economics / Q000453:epidemiology; D003710:Demography; D004345:Drug Industry; D006297:Health Services Accessibility; D006801:Humans; D008489:Medical Indigency; D009313:National Health Programs; D012955:Societies, Medical; D014481:United States
chemical_list: D002317:Cardiovascular Agents